Quantcast

Posts related to ‘AMGN’

pills

Deutsche Bank Firm on Biotech Stocks to Buy

Posted: May 15, 2013 at 8:10 am

Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...
Read Full Story »
Bull and Bear figures

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

Posted: May 8, 2013 at 4:05 pm

U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the U.K.rose 1.1% ...
Read Full Story »
health care

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

Posted: May 6, 2013 at 10:45 am

The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

Posted: May 1, 2013 at 4:08 pm

U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP lead ...
Read Full Story »
Stock Split Image

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Posted: May 1, 2013 at 10:45 am

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many ...
Read Full Story »
Wall St Bull statue

Top Wall Street Analyst Upgrades: Amgen, Buffett, Dunkin and More

Posted: May 1, 2013 at 8:15 am

Investors and traders are always on the lookout for fresh research ideas from Wall Street that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh ...
Read Full Story »
pills

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

Posted: April 30, 2013 at 10:30 am

Drug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc. ...
Read Full Story »
Stock Split Image

Major Companies That Refuse to Pay Dividends

Posted: April 26, 2013 at 6:55 am

Investors love dividends. This one investing component has comprised a major portion of total returns through time. The trend in recent years has been for companies to pay dividends and ...
Read Full Story »
Bull and Bear

Top Wall Street Analyst Downgrades Include Apple, Amgen, Banks

Posted: April 24, 2013 at 8:25 am

Investors frequently get to see the analyst upgrades and Buy ratings from Wall St. firms. They often do not get to see or they overlook the analyst downgrades and lists ...
Read Full Story »
Bull and Bear

Argus Makes Model Portfolio Changes (NUE, HCP, MDT, AMGN, HUM, ADI, JNPR, ELX, IPG)

Posted: April 11, 2013 at 8:15 am

Argus offers what is truly considered to be independent investment research. This gives the firm the lack of any or most of the traditional conflicts of interest that can be the ...
Read Full Story »
biotech

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

Posted: March 1, 2013 at 11:10 am

24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to ...
Read Full Story »
biotech

ETF Folly: Biotech ETFs, Nothing but Confusion

Posted: February 28, 2013 at 12:50 pm

24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...
Read Full Story »
Frankfurt bull and bear statues

Strange Stock Trends in the Fidelity Contrafund (WFC, JPM, IRE, KO, PEP, BRK-A, BIIB, AMGN, AAPL, GOOG, INTC, MSFT, XOM, CVX)

Posted: February 28, 2013 at 8:25 am

The Fidelity Contrafund has released its 2012 annual report for its shareholders. While the date is December 31, 2012, and the asset size is listed as more than $84 billion ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (AMGN, AOL, BBVA, BEBE, SCHW, CLGX, ELN, HIG, KR, NKE, SIAL, TSO, USAC, USB, VMW, WFC)

Posted: February 11, 2013 at 8:40 am

These are some of this Monday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Amgen Inc. (NASDAQ: AMGN) cut to Market Perform at William Blair. AOL ...
Read Full Story »
biotech

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Posted: February 8, 2013 at 10:10 am

Investing in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary ...
Read Full Story »